Pearl River Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,252
| Closed | -$618K | – | 515 |
|
|
2021
Q4 | $618K | Buy |
+7,252
| New | +$618K | 0.17% | 192 |
|
|
2020
Q3 | – | Sell |
-1,655
| Closed | -$202K | – | 427 |
|
|
2020
Q2 | $202K | Buy |
+1,655
| New | +$202K | 0.1% | 260 |
|
|
2020
Q1 | – | Sell |
-5,045
| Closed | -$542K | – | 650 |
|
|
2019
Q4 | $542K | Buy |
+5,045
| New | +$542K | 0.2% | 175 |
|
|
2019
Q1 | – | Sell |
-200
| Closed | -$14K | – | 629 |
|
|
2018
Q4 | $14K | Buy |
+200
| New | +$14K | 0.06% | 420 |
|